Browse > Article

Berberine Inhibits the Production of Lysophosphatidylcholine-induced Reactive Oxygen Species and the ERK1/2 Pathway in Vascular Smooth Muscle Cells  

Cho, Bong Jun (Yonsei Research Institute of Aging Science, Yonsei University)
Im, Eun Kyoung (Yonsei Research Institute of Aging Science, Yonsei University)
Kwon, Jun Hye (Yonsei Research Institute of Aging Science, Yonsei University)
Lee, Kyung-Hye (Yonsei Research Institute of Aging Science, Yonsei University)
Shin, Hye-Jin (Yonsei Research Institute of Aging Science, Yonsei University)
Oh, Jaewon (Yonsei Research Institute of Aging Science, Yonsei University)
Kang, Seok-Min (Yonsei Research Institute of Aging Science, Yonsei University)
Chung, Ji Hyung (Yonsei Research Institute of Aging Science, Yonsei University)
Jang, Yangsoo (Yonsei Research Institute of Aging Science, Yonsei University)
Publication Information
Molecules and Cells / v.20, no.3, 2005 , pp. 429-434 More about this Journal
Abstract
Lysophosphatidylcholine (lysoPC) induces vascular smooth muscle cell (VSMC) proliferation and migration, which has been proposed to initiate the intimal thickening in coronary atherosclerotic lesions. Berberine is an alkaloid in Berberis aquifolium and many other plants. Recently, it has been shown to have beneficial effects on the cardiovascular system, such as anti-hyperglycemic and cholesterol-lowering activity. In this study, we investigated its effects on lysoPC-induced VSMC proliferation and migration. Berberine inhibited lysoPC-induced DNA synthesis and cell proliferation in VSMCs, as well as migration of the lysoPC-stimulated VSMCs. It also inhibited the activation of extracellular signal-regulated kinases (ERKs) and reduced transcription factor AP-1 activity and the lysoPC-induced increases in intracellular reactive oxygen species (ROS). These results indicate that the inhibitory effects of berberine on lysoPC-stimulated VSMC proliferation and migration are attributable to inhibition of ROS generation and hence of activation of the ERK1/2 pathway. This suggests that berberine has potential in the prevention of atherosclerosis and restenosis.
Keywords
Berberine; ERK1/2; Lysophosphatidylcholine; Reactive Oxygen Species; Vascular Smooth Muscle Cells;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 18  (Related Records In Web of Science)
연도 인용수 순위
1 Choi, S. H., Cho, S. K., Kang, S. S., Bae, C. S., Bai, Y. H., et al. (2003) Effect of apitherapy in piglets with preweaning diarrhea. Am. J. Chin. Med. 31, 321-326   DOI   ScienceOn
2 Kang, D. G., Sohn, E. J., Kwon, E. K., Han, J. H., Oh, H., et al. (2002) Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascul. Pharmacol. 39, 281-286   DOI   ScienceOn
3 Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., et al. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344-1351   DOI   ScienceOn
4 Kugiyama, K., Sugiyama, S., Ogata, N., Oka, H., Doi, H., et al. (1999) Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143, 201-204   DOI   ScienceOn
5 Yamakawa, T., Tanaka, S., Kamei, J., Kadonosono, K., and Okuda, K. (2003) Pitavastatin inhibits vascular smooth muscle cell proliferation by inactivating extracellular signalregulated kinases 1/2. J. Atheroscler. Thromb. 10, 37-42   DOI   ScienceOn
6 Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., et al. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095   DOI   ScienceOn
7 Zeng, X. H., Zeng, X. J., and Li, Y. Y. (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92, 173-176   DOI   ScienceOn
8 Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., et al. (1996) Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98, 1897-1905   DOI   ScienceOn
9 Suenaga, H. and Kamata, K. (2003) Lysophosphatidylcholine activates extracellular-signal-regulated protein kinase and potentiates vascular contractile responses in rat aorta. J. Pharmacol. Sci. 92, 348-358   DOI
10 Chen, K., Thomas, S. R., and Keaney, J. F. Jr. (2003) Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic. Biol. Med. 35, 117-132   DOI   ScienceOn
11 Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H., and Huang, Y. (2001) Cardiovascular actions of berberine. Cardiovasc. Drug Rev. 19, 234-244   DOI   ScienceOn
12 Andres, V. and Castro, C. (2003) Antiproliferative strategies for the treatment of vascular proliferative disease. Curr. Vasc. Pharmacol. 1, 85-98   DOI
13 Wartenberg, M., Budde, P., De Marees, M., Grunheck, F., Tsang, S. Y., et al. (2003) Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab. Invest. 83, 87-98
14 Cho, H. M., Choi, S. H., Hwang, K. C., Oh, S. Y., Kim, H. G., et al. (2005) The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. Mol. Cells 19, 60-66
15 Kuo, C. L., Chi, C. W., and Liu, T. Y. (2004) The antiinflammatory potential of berberine in vitro and in vivo. Cancer Lett. 203, 127-137   DOI   ScienceOn
16 Della Rocca, G. J., van Biesen, T., Daaka, Y., Luttrell, D. K., Luttrell, L. M., et al. (1997) Ras-dependent mitogenactivated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J. Biol. Chem. 272, 19125-19132   DOI   ScienceOn
17 Takemoto, M. and Liao, J. K. (2001) Pleiotropic effects of 3- hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712-1719   DOI   ScienceOn
18 Tarpey, M. M. and Fridovich, I. (2001) Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89, 224-236   DOI   ScienceOn
19 Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., and Lewis, K. (2000) Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 97, 1433-1437
20 Yamakawa, T., Tanaka, S., Yamakawa, Y., Kamei, J., Numaguchi, K., et al. (2002) Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 22, 752-758   DOI   ScienceOn
21 Hong, Y., Hui, S. C., Chan, T. Y., and Hou, J. Y. (2002) Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am. J. Chin. Med. 30, 589-599   DOI   ScienceOn
22 Iizuka, N., Oka, M., Yamamoto, K., Tangoku, A., Miyamoto, K., et al. (2003) Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int. J. Cancer 107, 666-672   DOI   ScienceOn
23 Han, M. J., Kim, B. Y., Yoon, S. O., and Chung, A. S. (2003) Cell proliferation induced by reactive oxygen species is mediated via mitogen-activated protein kinase in chinese hamster lung fibroblast (V79) cells. Mol. Cells 15, 94-101
24 Yamakawa, T., Eguchi, S., Yamakawa, Y., Motley, E. D., Numaguchi, K., et al. (1998) Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertension 31, 248-253   DOI   ScienceOn
25 Kohno, M., Yokokawa, K., Yasunari, K., Minami, M., Kano, H., et al. (1998) Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation 98, 353-359   DOI   ScienceOn
26 Rivard, A. and Andres, V. (2000) Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol. Histopathol. 15, 557-571
27 Gunther, S., Alexander, R. W., Atkinson, W. J., and Gimbrone, M. A. Jr. (1982) Functional angiotensin II receptors in cultured vascular smooth muscle cells. J. Cell Biol. 92, 289- 298   DOI
28 Watanabe, T., Pakala, R., Katagiri, T., and Benedict, C. R. (2002) Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 39, 449-459   DOI   ScienceOn
29 Ko, W. H., Yao, X. Q., Lau, C. W., Law, W. I., Chen, Z. Y., et al. (2000) Vasorelaxant and antiproliferative effects of berberine. Eur. J. Pharmacol. 399, 187-196   DOI   ScienceOn
30 Kim, S. and Iwao, H. (2003) Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. J. Pharmacol. Sci. 91, 177-181   DOI
31 Martindale, J. L. and Holbrook, N. J. (2002) Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15   DOI   ScienceOn